The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic predictive biomarkers of anti-EGFR resistance in EGFR-mutated non-small-cell lung cancer: Impact of classical mutations, comutations and secondary CNVs.
 
Alejandro Olivares Hernández
Consulting or Advisory Role - Roche
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Merck; Nestle Health Science; Roche; Takeda
Research Funding - Persan Farma
Travel, Accommodations, Expenses - AstraZeneca; Fresenius; Lilly; Merck; MSD; Roche
 
Jose Maria Sayagues-Manzano
No Relationships to Disclose
 
Juan Carlos Montero González
No Relationships to Disclose
 
Jonnathan Roldán Ruiz
No Relationships to Disclose
 
Marta Rodríguez González
No Relationships to Disclose
 
Asuncion Diaz Serrano
No Relationships to Disclose
 
Jaime Ceballos
No Relationships to Disclose
 
María Ludeña de la Cruz
No Relationships to Disclose
 
María del Mar Abad Hernández
No Relationships to Disclose
 
Rebeca Lozano
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Pharma; AstraZeneca; Bayer; Ipsen; Janssen; Roche; Sanofi
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; Janssen Oncology; Merck/Pfizer; Orion
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb/Pfizer; Ipsen; Janssen; Merck; MSD; Roche; Sanofi
 
Molecular Tumour Board of Salamanca, Ávila, and Zamora (MTBSAZ) Investigators
No Relationships to Disclose